Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satheeshkumar Sellamuthu

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Recent Advances in Anti-Infective Drug Discovery|July 6, 2026
Rational Design, Synthesis, Molecular Docking, and Evaluation of Thioridazine-modified Tetrahydrocarbazole Derivatives as Antitubercular AgentsSatheeshkumar Sellamuthu, Boopathi Thangaraj, Dileep Kumar
Expert Opinion on Therapeutic Targets|May 6, 2017
Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discoverySatheeshkumar Sellamuthu, Meenakshi Singh, Ashok Kumar, et al.
Molecular Neurobiology|July 18, 2021
Role of TREM2 in Alzheimer's Disease: A Long Road AheadBhargavi Kulkarni, Dileep Kumar, Natália Cruz-Martins, et al.
Mini Reviews in Medicinal Chemistry|May 11, 2017
Phenothiazine: A Better Scaffold against TuberculosisSatheeshkumar Sellamuthu, Mohammad Faizan Bhat, Ashok Kumar, et al.
Biopolymers|July 1, 2020
Gelatin grafted poly(D,L-lactide) as an inhibitor of protein aggregation: An in vitro case studyChelladurai Karthikeyan Balavigneswaran, Gaurav Kumar, Chandrasekaran Vignesh Kumar, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Recent Advances in Anti-Infective Drug Discovery|July 6, 2026
Rational Design, Synthesis, Molecular Docking, and Evaluation of Thioridazine-modified Tetrahydrocarbazole Derivatives as Antitubercular AgentsSatheeshkumar Sellamuthu, Boopathi Thangaraj, Dileep Kumar
Expert Opinion on Therapeutic Targets|May 6, 2017
Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discoverySatheeshkumar Sellamuthu, Meenakshi Singh, Ashok Kumar, et al.
Molecular Neurobiology|July 18, 2021
Role of TREM2 in Alzheimer's Disease: A Long Road AheadBhargavi Kulkarni, Dileep Kumar, Natália Cruz-Martins, et al.
Mini Reviews in Medicinal Chemistry|May 11, 2017
Phenothiazine: A Better Scaffold against TuberculosisSatheeshkumar Sellamuthu, Mohammad Faizan Bhat, Ashok Kumar, et al.
Biopolymers|July 1, 2020
Gelatin grafted poly(D,L-lactide) as an inhibitor of protein aggregation: An in vitro case studyChelladurai Karthikeyan Balavigneswaran, Gaurav Kumar, Chandrasekaran Vignesh Kumar, et al.
Pageof 1